Scollr
Sign in Get app

Weekly research radar

Trending research this week

A weekly overview of research areas gaining momentum, built from recent papers, topic movement, and Scollr activity.

Reviewed weekly from recent paper activity, topic movement, and reader activity in Scollr.

Read this week's briefs All 16 trend briefs
Weekly Trend Briefs

Start with the fastest-moving fields

Concise reads on research areas with enough fresh activity to explain what changed, why it matters, and where to go deeper.

Recent papers Topic movement Reader activity Reviewed brief
Machine Learning in Materials Science Evidence window ending 2026-05-25

Machine Learning in Materials Science

Machine Learning in Materials Science shows 1,265 eligible recent papers and 1,262 commentary-ready papers in the current 30-day window, compared with 1,018 eligible papers in the prior window. The strongest evidence comes from 1 visible topic cluster and 8 representative papers. Several representative papers may be preprints, so this brief treats them as emerging signals rather than settled consensus.

1,265Recent 30-day eligible papers1,018Prior 30-day eligible papers1,262Commentary-ready papers
Quantum Computing Algorithms and Architecture Evidence window ending 2026-05-25

Quantum Computing Algorithms

Quantum Computing Algorithms shows 849 eligible recent papers and 848 commentary-ready papers in the current 30-day window, compared with 699 eligible papers in the prior window. The strongest evidence comes from 1 visible topic cluster and 8 representative papers. Several representative papers may be preprints, so this brief treats them as emerging signals rather than settled consensus.

849Recent 30-day eligible papers699Prior 30-day eligible papers848Commentary-ready papers
Computational Drug Discovery Methods Evidence window ending 2026-05-25

Computational Drug Discovery

Computational Drug Discovery shows 613 eligible recent papers and 613 commentary-ready papers in the current 30-day window, compared with 485 eligible papers in the prior window. The strongest evidence comes from 1 visible topic cluster and 8 representative papers. Several representative papers may be preprints, so this brief treats them as emerging signals rather than settled consensus.

613Recent 30-day eligible papers485Prior 30-day eligible papers613Commentary-ready papers
Recent brief previews

More fields to explore

4 recent previews shown here; 13 more in the full directory.

Explainable Artificial Intelligence (XAI) Evidence window ending 2026-05-25

Explainable AI

Explainable AI shows 1,508 eligible recent papers and 1,508 commentary-ready papers in the current 30-day window, compared with 1,285 eligible papers in the prior window. The strongest evidence comes from 1 visible topic cluster and 8 representative papers. Several representative papers may be preprints, so this brief treats them as emerging signals rather than settled consensus.

1,508Recent 30-day eligible papers
Smart Agriculture and AI Evidence window ending 2026-05-25

Smart Agriculture and AI

Smart Agriculture and AI shows 704 eligible recent papers and 704 commentary-ready papers in the current 30-day window, compared with 674 eligible papers in the prior window. The strongest evidence comes from 1 visible topic cluster and 8 representative papers. Several representative papers may be preprints, so this brief treats them as emerging signals rather than settled consensus.

704Recent 30-day eligible papers
Sepsis Diagnosis and Treatment Evidence window ending 2026-05-25

Sepsis Diagnosis and Treatment

Sepsis Diagnosis and Treatment shows 724 eligible recent papers and 721 commentary-ready papers in the current 30-day window, compared with 559 eligible papers in the prior window. The strongest evidence comes from 1 visible topic cluster and 8 representative papers. Several representative papers may be preprints, so this brief treats them as emerging signals rather than settled consensus.

724Recent 30-day eligible papers
Dementia and Cognitive Impairment Research Evidence window ending 2026-05-25

Dementia and Cognitive Impairment

Dementia and Cognitive Impairment shows 689 eligible recent papers and 687 commentary-ready papers in the current 30-day window, compared with 586 eligible papers in the prior window. The strongest evidence comes from 1 visible topic cluster and 8 representative papers. Several representative papers may be preprints, so this brief treats them as emerging signals rather than settled consensus.

689Recent 30-day eligible papers
Browse all 16 trend briefs
Supporting evidence

Current papers to scan

A compact read on papers gaining traction near the same topics.

02
Fetal and Pediatric Neurological DisordersOpen Access

Orientation-Aware Diffusion Super-Resolution for 3T-Like Fetal MRI from Routine 1.5T Scans.

Xinliu Zhong, Yun Wang, Ruiying Liu

inhomogeneity limits wide adoption for routine fetal imaging. Consequently, most clinical examinations are performed at 1.5T, where greater motion tolerance comes at the cost of lower SNR, reduced gray-white matter contrast, and partial-volume blurring - factors that undermine...

PubMed - 2026

03
Explainable Artificial Intelligence (XAI)

Explain Decisions, Not Just Predictions! An Evaluation Of Ai Agent Transparency

Kai Heinrich, Sabahat Nagihan Köksalan Arslan, Armin Keshavarzi

While the role of transparency in adopting AI-based decision support systems has been widely discussed, the role of explainability in adopting autonomous decision systems, widely known as AI agents, remains widely undiscovered. Empirical findings show that when a system is pre...

Journal of the Association for Information Systems - 2026

05
Prostate Cancer Treatment and Research

Comparative Detection Performance of PSMA and Non-PSMA PET Tracers in Recurrent and Primary Prostate Cancer: A Systematic Review and Network Meta-Analysis.

Yu-Erh Huang, Jing‐Ren Tseng, Ya-Ting Huang

PURPOSE: Prostate-specific membrane antigen (PSMA)-targeted positron emission tomography (PET) tracers have reshaped prostate cancer (PC) imaging, supplementing non-PSMA options such as choline-based agents. However, direct comparative performance data across tracers remain sc...

PubMed - 2026